컨센트릭스 코퍼레이션
DE ˙ DB ˙ US20602D1019
€23.43 ↓ -0.36 (-1.51%)
2026-06-04
주가
SecurityDE:CO8 / Concentrix Corporation
InstitutionMorgan Stanley
Latest Disclosed Ownership904,364 shares
Latest Disclosed Value $ 24,743,425
Morgan Stanley reports 17.65% decrease in ownership of CO8 / Concentrix Corporation

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 904,364 shares of Concentrix Corporation (DE:CO8) valued at $25,322,192 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,098,147 shares of Concentrix Corporation. This represents a change in shares of -17.65% during the quarter. The current value of the position is $21,189,249 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CONCENTRIX COM 20602D101 904,364 -193,783 -17.65 24,743 -45.81 0.0015
2026-05-27 2025-12-31 13F/A-1 CONCENTRIX COM 20602D101 1,098,147 201,072 22.41 45,661 10.29 0.0027
2026-02-13 2025-12-31 13F CONCENTRIX COM 20602D101 1,098,147 201,072 45,661 0.0027
2026-05-27 2025-09-30 13F/A-1 CONCENTRIX COM 20602D101 897,075 130,098 16.96 41,400 2.13 0.0025
2025-11-14 2025-09-30 13F CONCENTRIX COM 20602D101 897,075 130,098 41,400 0.0025
2025-08-15 2025-06-30 13F CONCENTRIX COM 20602D101 766,977 -68,714 -8.22 40,539 -12.82 0.0026
2025-05-15 2025-03-31 13F CONCENTRIX COM 20602D101 835,691 48,553 6.17 46,498 36.52 0.0033
2025-05-15 2024-12-31 13F/A-1 CONCENTRIX COM 20602D101 787,138 288,065 57.72 34,059 33.16 0.0024
2025-02-14 2024-12-31 13F CONCENTRIX COM 20602D101 787,138 288,065 34,059 0.0024
2025-05-14 2024-09-30 13F/A-2 CONCENTRIX COM 20602D101 499,073 -66,078 -11.69 25,578 -28.48 0.0019
2025-02-14 2024-09-30 13F/A-1 CONCENTRIX COM 20602D101 499,073 -66,078 25,578 0.0019
2024-11-14 2024-09-30 13F CONCENTRIX COM 20602D101 499,073 -66,078 25,578 0.0019
2025-05-14 2024-06-30 13F/A-2 CONCENTRIX COM 20602D101 565,151 143,879 34.15 35,763 28.20 0.0028
2024-10-17 2024-06-30 13F/A-1 CONCENTRIX COM 20602D101 565,151 143,879 35,763 0.0028
2024-08-14 2024-06-30 13F CONCENTRIX COM 20602D101 565,151 143,879 35,763 0.0028
2024-10-17 2024-03-31 13F/A-2 CONCENTRIX COM 20602D101 421,272 -208,951 -33.16 27,897 -54.93 0.0022
2024-08-16 2024-03-31 13F/A-1 CONCENTRIX COM 20602D101 421,272 -208,951 27,897 0.0003
2024-05-15 2024-03-31 13F CONCENTRIX COM 20602D101 421,272 -208,951 27,897 0.0022
2024-08-16 2023-12-31 13F/A-1 CONCENTRIX COM 20602D101 630,223 273,600 76.72 61,894 116.65 0.0055
2024-02-13 2023-12-31 13F CONCENTRIX COM 20602D101 630,223 273,600 61,894 0.0055
2023-11-15 2023-09-30 13F CONCENTRIX COM 20602D101 356,623 80,947 29.36 28,569 28.34 0.0029
2023-08-14 2023-06-30 13F CONCENTRIX COM 20602D101 275,676 38,278 16.12 22,261 -22.86 0.0022
2023-05-15 2023-03-31 13F CONCENTRIX COM 20602D101 237,398 53,102 28.81 28,856 17.58 0.0031
2023-02-14 2022-12-31 13F CONCENTRIX COM 20602D101 184,296 41,968 29.49 24,541 54.44 0.0028
2022-11-14 2022-09-30 13F CONCENTRIX COM 20602D101 142,328 -65,423 -31.49 15,890 -43.61 0.0022
2022-10-27 2022-06-30 13F/A-1 CONCENTRIX COM 20602D101 207,751 115,893 126.17 28,179 84.15 0.0037
2022-08-15 2022-06-30 13F CONCENTRIX COM 20602D101 207,751 115,893 28,179 0.0007
2022-10-27 2022-03-31 13F/A-1 CONCENTRIX COM 20602D101 91,858 -2,725 -2.88 15,302 -9.42 0.0021
2022-05-13 2022-03-31 13F CONCENTRIX COM 20602D101 91,858 -2,725 15,302 0.0021
2022-02-14 2021-12-31 13F CONCENTRIX COM 20602D101 94,583 -50,797 -34.94 16,894 -34.35 0.0021
2021-11-15 2021-09-30 13F CONCENTRIX COM 20602D101 145,380 -48,862 -25.16 25,733 -17.61 0.0035
2021-08-23 2021-06-30 13F/A-1 CONCENTRIX COM 20602D101 194,242 142,390 274.61 31,235 302.36 0.0041
2021-08-16 2021-06-30 13F CONCENTRIX COM 20602D101 194,242 142,390 31,235 0.0009
2021-05-17 2021-03-31 13F CONCENTRIX COM 20602D101 51,852 -135,282 -72.29 7,763 -57.97 0.0011
2021-02-16 2020-12-31 13F CONCENTRIX COM 20602D101 187,134 187,134 18,470 0.0029
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.